Relationship between antidiabetic treatment with QT dispersion during acute coronary syndromes in type 2 diabetes: Comparison between patients receiving sulfonylureas and insulin

Experimental and Clinical Endocrinology and Diabetes

Volumn 113, Issue 5, 2005, Pages 298-301

  Tentolouris, N ^a   Matsagura, M ^a   Psallas, M ^a   Chatzizacharias, A ^b   Fotia, M ^a   Arvanitis, M ^a   Katsilambros, N ^a,c  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b LAIKO GENERAL HOSPITAL   (Greece)

^c NONE   (Greece)

Author keywords

Acute coronary syndromes; Myocardial infarction; QT dispersion; QT interval; Sulfonylureas; Type 2 diabetes

Indexed keywords

INSULIN; METFORMIN; SULFONYLUREA;

ACUTE HEART FAILURE; ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORONARY CARE UNIT; ELECTROCARDIOGRAM; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; QT DISPERSION; QT INTERVAL; UNSTABLE ANGINA PECTORIS;

AGED; ANGINA, UNSTABLE; CHOLESTEROL, LDL; CORONARY DISEASE; DIABETES MELLITUS, TYPE 2; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; INSULIN; LINEAR MODELS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; SULFONYLUREA COMPOUNDS;

EID: 20944450648     PISSN: 09477349     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-865641     Document Type: Article

References (18)

1. + channels and insulin secretion: their role in health and disease. Diabetologia 1999; 42: 903-919
2. Bazett HC. An analysis of the time relations of the electrocardiogram. Heart 1920; 7: 353-370
3. Bednar MM, Harrigan EP, Anziano RJ, Camm AJ, Ruskin JN. The QT interval. Prog Cardiovasc Dis 2001; 43 (Suppl 1): 1-45
4. Engler RL, Yellon DM. Sulfonylurea K-ATP blockade in type II diabetes and preconditioning in cardiovascular disease: time for reconsideration. Circulation 1996; 94: 2297-2301
5. Gross GJ, Auchampach JA. Role of ATP dependent potassium channels in myocardial ischaemia. Cardiovasc Res 1992; 26: 1011-1016
6. Jain H, Avasthi R. Correlation between dispersion of repolarization (QT dispersion) and ventricular ectopic beat frequency in patients with acute myocardial infarction: a marker for risk of arrhythmogenesis? Int J Cradiol 2004; 93: 69-73
7. Klepzig H, Kober G, Matter C, Luus H, Schneider H, Boedeker KH, Kiowski W, Amann FW, Gruber D, Harris S, Burger W. Sulfonylureas and ischaemic preconditioning; a double-blind, placebo-controlled evaluation of glimepiride and glibenclamide. Eur Heart J 1999; 20: 439-446
8. Lebovitz HE. Insulin secretagogues: old and new. Diabetes Reviews 1999; 7: 140-153
9. Lee CY. Gating mechanisms of ATP sensitive potassium channels: implication in reperfusion injury and preconditioning. Cardiovasc Res 1994; 28: 729-734
10. Meier JJ, Deifuss S, Klamann A, Schmiegel W, Nauck MA. Influence of an antidiabetic treatment with sulfonylurea drugs on long-term survival after acute myocardial infarction in patients with type 2 diabetes. The Langendreer Myocardial infarction and Blood glucose in Diabetic patients Assessment (LAMBDA). Exp Clin Endocrinol Diabetes 2003; 111: 344-350
11. Meinert CL, Knatterud GL, Prout TE, Klimt CR. A study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. Diabetes 1970; 19 (Suppl): 789-830
12. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 1986; 74: 1124-1136
13. Nieszner E, Posa I, Kocsis E, Pogatsa G, Preda I, Koltai MZ. Influence of diabetic state and that of different sulfonylureas on the size of myocardial infarction with and without ischemic preconditioning in rabbits. Exp Clin Endocrinol Diabetes 2002; 110: 212-218
14. Okishige K, Yamashita K, Yoshinaga H, Azegami K, Satoh T, Goseki Y, Fujii S, Ohira H, Satake S. Electrophysiologic effects of ischemic preconditioning on QT dispersion during coronary angioplasty. J Am Coll Cardiol 1996; 28: 70-73
15. Riveline JP, Danchin N, Ledru F, Varroud-Vial M, Charpentier G. Sulfonylureas and cardiovascular effects: from experimental data to clinical use. Available data in humans and clinical applications. Diabetes Metab 2003; 29: 207-222
16. Suzuki M, Nishizaki M, Arita M, Ashikaga T, Yamawake N, Kakuta T, Numano F, Hiraoka M. Increased QT dispersion in patients with vasospastic angina. Circulation 1998; 98: 435-440
17. Vegh A, Papp JG. Haemodynamic and other effects of sulphonylurea drugs on the heart. Diabet Res Clin Pract 1996; 31 (Suppl 1): S43-S53
18. Zabel M, Klingenheben T, Franz MR, Hohnloser SH. Assessment of QT dispersion for prediction of mortality or arrhythmic events after myocardial infarction: results of a prospective, long-term follow-up study. Circulation 1998; 97: 2543-2550